Table 1 Patient Characteristics and Statin Treatment
Treatment Groups | Age (year)/Gender | Baseline Treatment (mg) | Treatment During Study (mg) |
|---|---|---|---|
A. Statin Increase: Initiation | Â | Â | Â |
1 | 79/F | none | atorvastatin 80 |
2 | 72/M | none | simvastatin 20 |
3 | 68/F | none | atorvastatin 40 |
4 | 56/F | none | pravastatin 40 |
5 | 86/M | none | atorvastatin 20 |
6 | 46/M | none | rosuvastatin 40 |
Statin Increase | Â | Â | Â |
7 | 58/M | atorvastatin 10 | atorvastatin 80 |
8 | 72/F | simvastatin 10 | atorvastatin 80 |
9 | 87/M | lovastatin 40 | atorvastatin 80 |
10 | 61/M | simvastatin 40 | simvastatin 80 |
11 | 73/M | pravastatin 80 | atorvastatin 80 |
12 | 65/M | atorvastatin 10 | atorvastatin 40 |
13 | 66/M | simvastatin 20 | simvastatin 40 |
B. Statin Maintain | Â | Â | Â |
14 | 62/M | atorvastatin 40 | simvastatin 20 |
15 | 61/M | atorvastatin 10 | simvastatin 20 |
16 | 71/M | lovastatin 40 | lovastatin 40 |
17 | 64/M | simvastatin 80 | simvastatin 80 |
18 | 57/M | simvastatin 40 (noncompliant with prescribed treatment) | simvastatin 40 (noncompliant with prescribed treatment) |
19 | 71/M | simvastatin 5 | simvastatin 5 |
20 | 63/M | Ezetimibe 10/simvastatin 20 | Ezetimibe 10/simvastatin 20 |
21 | 56/F | simvastatin 10 | simvastatin10 |
22 | 65/M | atorvastatin 10 | atorvastatin 10 |
23 | 82/M | simvastatin 20 | simvastatin 20 |
24 | 60/M | simvastatin 20 | simvastatin 20 |
25 | 81/F | atorvastatin 10 | atorvastatin 10 |
26 | 61/M | pravastatin 40 | pravastatin 40 |